Reproductive Genetics Market Current Status, In-depth Analysis and Forecast Outlook 2030


Posted May 6, 2021 by bisrsrch

Focus on Procedure Type, Product Type, Technology, Application Type, Country Data (15 countries) - Analysis and Forecast, 2020-2030
 
The global reproductive genetics market generated $4,402.8 million in 2020. The highest market share of 38.81% among all the regions was held by North America owing to the presence of a large number of genetic testing companies and a high level of awareness for such tests.

Read Report Overview at: https://bisresearch.com/industry-report/reproductive-genetics-market.html

Various regulatory bodies across the world claim that the implementation of reproductive genetics tests such as NIPT and the subsequent rise in uptake of pre-natal testing is likely to increase the incidence of abortions. Therefore, professional organizations such as the American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis (ISPD), U.S. National Society of Genetic Counselors (NSGC), and the Japan Society of Obstetrics and Gynaecology have set up guidelines that limit the use of non-invasive pre-natal testing only to pregnant women at high risk of chromosomal aneuploidies. The women at high risk of fetal chromosomal aneuploidies include women aged 35 years and older, women with a personal or family history of aneuploidies, and those with positive results from conventional screening methods such as ultrasonography and maternal serum tests indicating a high risk of aneuploidies.

According to the ACOG, tests like NIPT should not be considered routine laboratory testing, and instead, should be seen as an informed patient choice post-pre-test counseling. In many countries like India and China, where termination of female fetuses is considered illegal, implementation of pre-natal testing for reproductive genetics has raised a serious ethical concern since these tests are misused to illegally determine the sex of the fetus.

In many Middle Eastern and African countries, the reproductive genetic testing market players are facing huge challenges due to their ethical and cultural norms and also due to their skepticism toward these tests. Countries like Saudi Arabia, the U.A.E., Turkey, Iraq, Oman, and Iran have economic and infrastructural support but have still not shown any green signals to these tests due to the shortage of educational and government development programs leading to a lack of awareness regarding these tests.

Obtain the Sample Report at: https://bisresearch.com/requestsample?id=1112&type=download

In the five years (January 2017-February 2021), the market witnessed 23 product offerings, five product approvals, 16 partnerships and alliances, nine mergers and acquisitions, and five business expansions. The increasing awareness for genetic testing with an answer for genetic abnormalities caused has majorly attributed to the growing prominence for reproductive genetic testing.

About BIS Research:

BIS Research, a premium market intelligence company, offers in-depth insights and consulting to Fortune 500 companies. We are established and known for tracking the growth of deep technologies across key industry verticals and the subsequent challenges and opportunities associated with deep tech across markets, applications, and products.

With more than 500 clients, over 7000 plus primary interviews, and approximately 200 reports published in a year, BIS Research has set an interesting growth trajectory for itself. We provide market estimations, analysis on emerging high-growth applications, technology analysis, highly segmented granular country-level market data, and other important market parameters that come in handy for our clients during strategic decision-making.

We publish a wide gamut of syndicated market studies across industry verticals. In addition, bespoke market studies are another area where BIS Research excels at, along with consulting services.

BIS healthcare vertical offers intelligence in the healthcare technology market for medical devices, digital health, life sciences, robotics and imaging, information technology, MRD testing, and other emerging healthcare technologies, covering the entire industry spectrum. In the past five years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating ‘Top 25 Voices’ in precision medicine on its Insight Monk platform for the past two years successfully.

Contact:

Bhavya Banga
Email: [email protected]
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By BIS RSRCH
Business Address 39111 PASEO PADRE PKWY STE 313,
Country United States
Categories Business , News , Research
Tags reproductive genetics market
Last Updated May 6, 2021